Eugenio Aringhieri

Dompe Group SpA (Dompé Group SpA) operates as a holding company with interests in pharmaceutical development and medical research. It provides services through its subsidiaries such as Dompé Farmaceutici, Dompé Biotec , Dompé, Dompé International, Dompé Pharma, Biogen Dompé and Biogen Dompé AG. The company is headquartered in Milan, Italy.

Dompe Farmaceutici SpA operates as a biopharmaceutical company. It develops pharmaceutical and biotechnological drugs. The firm provides updating and scientific assistance services to doctors of general medicine, paediatrics, pneumology, otology, orthopaedics, rheumatology, physiatrist, odontology, accident and emergency and first aid stations. The company was founded by Franco Dompé in 1940 and is headquartered in Milan, Italy.

Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France.

Part of Dompé SpA, Anabasis SRL provides biopharmaceutical research and development services. The company is based in Milan, Italy. The Italian company was founded by Francesco Sinigaglia. Anabasis was acquired by Dompé SpA on February 27, 2012.